Clinical homologous recombination repair gene reversion analysis identifies mechanisms of resistance to PARP inhibitors and platinum‐chemotherapy

Benzer Materyaller

• Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib
  Yazar:: Gehan Botrus, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-10-01)
• BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer
  Yazar:: Heidelinde Fiegl, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-11-01)
• Treatment for metastatic triple-negative breast cancer with homologous recombination deficiency: a Bayesian network meta-analysis
  Yazar:: Hangcheng Xu, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-04-01)
• Clinical homologous recombination repair gene reversion analysis identifies mechanisms of resistance to PARP inhibitors and platinum‐chemotherapy
  Yazar:: Yan Jia, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-06-01)
• Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study
  Yazar:: Alfonso Cortés, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-12-01)